引用本文
  •    [点击复制]
  •    [点击复制]
PDF HTML全文阅读
本文已被:浏览 33次   下载 0 本文二维码信息
码上扫一扫!
清热凉血方联合重组人酸性成纤维细胞生长因子对肛周脓肿患者术后创面愈合、疼痛及血清炎症因子的影响
孙永永,戚学华,夏青
邢台市人民医院外科河北邢台054001;邢台市中医医院肛肠科河北邢台 054000
摘要:
目的:探究清热凉血方联合重组人酸性成纤维细胞生长因子(rh-aFGF)对肛周脓肿(PA)患者术后创面愈合、疼痛及血清炎症因子的影响。方法:选取2023年12月—2024年12月于本院进行一次性PA根治术的PA患者184例,按随机数字表法随机分为rh-aFGF组和方剂组两组,每组各92例。rh-aFGF组采用rh-aFGF治疗,方剂组采用rh-aFGF联合清热凉血方治疗,均治疗14 d,比较两组患者的中医证候积分、创面愈合情况、创面相关指标评分、炎症因子、血管生长因子及临床疗效。结果:治疗14 d后,方剂组的创面愈合率高于rh-aFGF组,创面祛腐时间和创面愈合时间短于rh-aFGF组(P <0.05)。治疗后,两组各项中医证候积分、疼痛视觉模拟评分(VAS)、水肿评分及渗液评分均低于治疗前,且方剂组低于rh-aFGF组(P <0.05),两组肉芽生长评分高于治疗前,且方剂组高于rh-aFGF组(P <0.05);治疗后,两组基质金属蛋白酶-2(MMP-2)、激活素A(ACTA)及血清干扰素-γ(IFN-γ)水平均低于治疗前,且方剂组低于rh-aFGF组(P <0.05);治疗后,两组基质细胞衍生因子-1α(SDF-1α)、血管内皮生长因子(VEGF)、血管生成素-2(Ang-2)水平均高于治疗前,且方剂组高于rh-aFGF组(P <0.05);治疗后,两组肛管最大收缩压、肛管静息压、直肠最大耐受阈值高于治疗前,且方剂组高于rh-aFGF组(P <0.05)。结论:清热凉血方联合rh-aFGF可促进PA患者术后创面愈合,减轻疼痛,降低炎症因子水平并提高血管生长因子水平,疗效良好。
关键词:  清热凉血方  重组人酸性成纤维细胞生长因子  肛周脓肿  创面愈合  疼痛  炎症因子
DOI:10.3969/j.issn.1007-6948.2026.04.008
投稿时间:2026-01-08
基金项目:河北省中医药类科学研究课题计划项目(2026478)
Effects of the Qingre Liangxue formula combined with recombinant human acidic fibroblast growth factor on postoperative wound healing, pain, and serum inflammatory factors in patients with perianal abscess
SUN Yong-yong,QI Xue-hua,XIA Qing
Abstract:
Objective To explore the effects of the Qingre Liangxue formula combined with recombinant human acidic fibroblast growth factor (rh-aFGF) on postoperative wound healing, pain, and serum inflammatory factors in patients with perianal abscess (PA). Methods In this study, PA patients who underwent one-time PA radical surgery in our hospital from December 2023 to December 2024 were selected and assigned into the rh-aFGF group and the formula group, with 92 cases in each group. The rh-aFGF group was treated with rh-aFGF, and the formula group was treated with rh-aFGF and Qingre Liangxue formula. After 14 days of therapy, the TCM syndrome score, wound healing condition, wound related index score, inflammatory factors, vascular growth factors and clinical efficacy were evaluated. Results The formula group had a higher wound healing rate than the rh-aFGF group, and shorter wound debridement time and wound healing time than the rh-aFGF group (P <0.05). After therapy, the scores of various TCM syndromes, VAS scores, edema scores and exudate scores in the formula group were all lower than those in the rh-aFGF group(P <0.05), while the granulation tissue growth score was higher than that in the rh-aFGF group (P <0.05). After therapy, the levels of MMP-2, ACTA and IFN-γ in the formula group were all lower than those in the rh-aFGF group (P <0.05), and the levels of SDF-1α, VEGF and Ang-2 were all higher than those in the rh-aFGF group(P <0.05). The maximum systolic pressure of the anal canal, the resting pressure of the anal canal, and the maximum tolerance threshold of the rectum in the formula group were higher than those in the rh-aFGF group(P <0.05). Conclusion The Qingre Liangxue formula combined with rh-aFGF can promote postoperative wound healing in PA patients, relieve pain, reduce inflammatory factors, increase the levels of vascular growth factors, and has a good therapeutic effect.
Key words:  Qingre Liangxue formula  recombinant human acidic fibroblast growth factor  perianal abscess  wound healing  pain  inflammatory factor

用微信扫一扫

用微信扫一扫